J Pathol Transl Med.  2020 Sep;54(5):361-366. 10.4132/jptm.2020.07.17.

Thyroid fine-needle aspiration cytology in Taiwan: a nationwide survey and literature update

• Chen CC
• Hang JF
• Liu CY
• Wang YH
• Lai CR

• KMID: 2506269
• DOI: http://doi.org/10.4132/jptm.2020.07.17

Abstract

In Taiwan, thyroid fine-needle aspiration cytology is easily accessible and reliable for evaluating thyroid nodules. The sonographic pattern plays a major role and is the deciding factor for aspiration. We conducted a nationwide survey in 2017 and it revealed that 31% of laboratories had adopted The Bethesda System for Reporting Thyroid Cytopathology. There was a relatively high unsatisfactory rate (24.04%) and low rates of indeterminate diagnoses, including atypia of undetermined significance/follicular lesions of undetermined significance: 4.87%, and follicular neoplasm/suspicious for a follicular neoplasm: 0.35%. Moreover, the risks of malignancy in benign, atypia of undetermined significance, and suspicious for a follicular neoplasm were relatively high. These may reflect strict diagnostic criteria for indeterminate categories and better patient selection for surgery. Improvements in specimen sampling and continuing education programs are crucial. Newly-developed thyroid cytology technologies, such as immunocytochemistry, molecular testing, and computerized cytomorphometry, may further facilitate cytology diagnoses.

Keyword

Cytology; Fine-needle aspiration; Taiwan; Thyroid; Thyroidectomy

Reference

References

1. Chang HY, Lin JD, Chen JF, et al. Correlation of fine needle aspiration cytology and frozen section biopsies in the diagnosis of thyroid nodules. J Clin Pathol. 1997; 50:1005–9.

2. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111:508–16.

3. Trimboli P, Treglia G, Guidobaldi L, et al. Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis. Endocrine. 2014; 46:52–9.

4. Kakudo K, Higuchi M, Hirokawa M, Satoh S, Jung CK, Bychkov A. Thyroid FNA cytology in Asian practice-Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas. Cytopathology. 2017; 28:455–66.

5. Jung CK, Hong S, Bychkov A, Kakudo K. The use of fine-needle aspiration (FNA) cytology in patients with thyroid nodules in Asia: a brief overview of studies from the Working Group of Asian Thyroid FNA Cytology. J Pathol Transl Med. 2017; 51:571–8.

6. Hang JF, Hsu CY, Lai CR. Thyroid fine-needle aspiration in Taiwan: the history and current practice. J Pathol Transl Med. 2017; 51:560–4.

7. Lin JH, Chiang FY, Lee KW, Ho KY, Kuo WR. The role of neck ultrasonography in thyroid cancer. Am J Otolaryngol. 2009; 30:324–6.

8. Hsiao YL, Chang TC. Ultrasound evaluation of thyroid abnormalities and volume in Chinese adults without palpable thyroid glands. J Formos Med Assoc. 1994; 93:140–4.

9. Tay SY, Chen CY, Chan WP. Sonographic criteria predictive of benign thyroid nodules useful in avoiding unnecessary ultrasound-guided fine needle aspiration. J Formos Med Assoc. 2015; 114:590–7.

10. Wu MH, Chen CN, Chen KY, et al. Quantitative analysis of dynamic power Doppler sonograms for patients with thyroid nodules. Ultrasound Med Biol. 2013; 39:1543–51.

11. Wu CW, Dionigi G, Lee KW, et al. Calcifications in thyroid nodules identified on preoperative computed tomography: patterns and clinical significance. Surgery. 2012; 151:464–70.

12. Lee KL, Chen TJ, Won GS, et al. The use of fine needle aspiration and trends in incidence of thyroid cancer in Taiwan. J Chin Med Assoc. 2018; 81:164–9.

13. Poller DN, Stelow EB, Yiangou C. Thyroid FNAC cytology: can we do it better? Cytopathology. 2008; 19:4–10.

14. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27:1341–6.

15. Shih SR, Li HY, Hsiao YL, Chang TC. Prognostic significance of cytologic features in fine-needle aspiration cytology samples of papillary thyroid carcinoma: preliminary report. Thyroid. 2006; 16:775–80.

16. Vuong HG, Ngo HTT, Bychkov A, et al. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and meta-analysis. Cancer Cytopathol. 2020; 128:238–49.

17. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016; 2:1023–9.

18. Lloyd RV, Osamura RY, Kloppel G, Rosi J. WHO classification of tumours of endocrine organs. 4th ed. 10. Lyon: IARC Press;2017.

19. Hang JF, Westra WH, Zhou AG, Cooper DS, Ali SZ. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategories. Cancer Cytopathol. 2018; 126:309–16.

20. Hang JF, Westra WH, Cooper DS, Ali SZ. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier. Cancer Cytopathol. 2017; 125:683–91.

21. Bychkov A, Keelawat S, Agarwal S, et al. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology. 2018; 50:411–7.

22. Tung CC, Chang TC, Hsieh HC. Value of immunoperoxidase staining of thyroglobulin in fine needle aspiration cytology of thyroid diseases. Acta Cytol. 1995; 39:396–401.

23. Chang TC, Tung CC, Hsiao YL, Chen MH. Immunoperoxidase staining in the differential diagnosis of parathyroid from thyroid origin in fine needle aspirates of suspected parathyroid lesions. Acta Cytol. 1998; 42:619–24.

24. Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: 2016 update. Endocr Pract. 2016; 22:622–39.

25. Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett. 2003; 191:223–7.

26. Nikiforov YE. Role of molecular markers in thyroid nodule management: then and now. Endocr Pract. 2017; 23:979–88.

27. Shih SR, Chang YC, Li HY, et al. Preoperative prediction of papillary thyroid carcinoma prognosis with the assistance of computerized morphometry of cytology samples obtained by fine-needle aspiration: preliminary report. Head Neck. 2013; 35:28–34.

28. Shih SR, Jan IS, Chen KY, et al. Computerized cytological features for papillary thyroid cancer diagnosis-preliminary report. Cancers (Basel). 2019; 11:1645.

29. Chen CC, Chen WC, Peng SL, Huang SM. Diffuse sclerosing variant of thyroid papillary carcinoma: diagnostic challenges occur with Hashimoto’s thyroiditis. J Formos Med Assoc. 2013; 112:358–62.

30. Kung FP, Chen CC. Mixed medullary and papillary carcinoma of the thyroid: a case report. Tzu Chi Med J. 2015; 27:133–4.

31. Liu FH, Liou MJ, Hsueh C, Chao TC, Lin JD. Thyroid follicular neoplasm: analysis by fine needle aspiration cytology, frozen section, and histopathology. Diagn Cytopathol. 2010; 38:801–5.

32. Lee TI, Yang HJ, Lin SY, et al. The accuracy of fine-needle aspiration biopsy and frozen section in patients with thyroid cancer. Thyroid. 2002; 12:619–26.

33. Agarwal S, Bychkov A, Jung CK, et al. The prevalence and surgical outcomes of Hurthle cell lesions in FNAs of the thyroid: a multi-institutional study in 6 Asian countries. Cancer Cytopathol. 2019; 127:181–91.

34. Chen CC, Chi CY. Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan. Cancer Cytopathol. 2020; 128:309–16.

35. Chen CC, Chi CY. Reply to rapid on-site evaluation and the COVID-19 pandemic. Cancer Cytopathol. 2020; Jun. 5. [Epub]. https://doi.org/10.1002/cncy.22296.